Noreen Henig

1.6k total citations
36 papers, 1.2k citations indexed

About

Noreen Henig is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Noreen Henig has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Noreen Henig's work include Cystic Fibrosis Research Advances (22 papers), Tracheal and airway disorders (8 papers) and Neonatal Respiratory Health Research (7 papers). Noreen Henig is often cited by papers focused on Cystic Fibrosis Research Advances (22 papers), Tracheal and airway disorders (8 papers) and Neonatal Respiratory Health Research (7 papers). Noreen Henig collaborates with scholars based in United States, United Kingdom and Germany. Noreen Henig's co-authors include Brian Morrissey, Diana Bilton, Mark H. Gotfried, Moira L. Aitken, Jane L. Burns, Peter N. Kao, Tomasz M. Ziedalski, George Retsch‐Bogart, Susan S. Jacobs and Stephen J. Ruoss and has published in prestigious journals such as Blood, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Noreen Henig

36 papers receiving 1.2k citations

Peers

Noreen Henig
Shaoyan Zhang China
K. Randall Young United States
Amy O’Brien-Ladner United States
Dominique Grenet France
Rita Padoan Italy
David A. Waltz United States
Meng‐Chih Lin Taiwan
Nobuhiko Nagata Japan
J. Alastair Innes United Kingdom
Daniel Gelfond United States
Shaoyan Zhang China
Noreen Henig
Citations per year, relative to Noreen Henig Noreen Henig (= 1×) peers Shaoyan Zhang

Countries citing papers authored by Noreen Henig

Since Specialization
Citations

This map shows the geographic impact of Noreen Henig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noreen Henig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noreen Henig more than expected).

Fields of papers citing papers by Noreen Henig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noreen Henig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noreen Henig. The network helps show where Noreen Henig may publish in the future.

Co-authorship network of co-authors of Noreen Henig

This figure shows the co-authorship network connecting the top 25 collaborators of Noreen Henig. A scholar is included among the top collaborators of Noreen Henig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noreen Henig. Noreen Henig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Saxena, Amit, et al.. (2023). POS1128 ZETOMIPZOMIB (KZR-616) TREATMENT RESULTS IN CLINICALLY MEANINGFUL RENAL RESPONSES IN PATIENTS WITH LUPUS NEPHRITIS. Annals of the Rheumatic Diseases. 82. 891–892. 3 indexed citations
3.
Beumer, Wouter, Jim Swildens, Teresinha Leal, et al.. (2019). Evaluation of eluforsen, a novel RNA oligonucleotide for restoration of CFTR function in in vitro and murine models of p.Phe508del cystic fibrosis. PLoS ONE. 14(6). e0219182–e0219182. 22 indexed citations
4.
Dřevı́nek, Pavel, Tacjana Pressler, Marco Cipolli, et al.. (2019). Antisense oligonucleotide eluforsen is safe and improves respiratory symptoms in F508DEL cystic fibrosis. Journal of Cystic Fibrosis. 19(1). 99–107. 49 indexed citations
5.
Brinks, Vera, et al.. (2019). The Cystic Fibrosis-Like Airway Surface Layer Is not a Significant Barrier for Delivery of Eluforsen to Airway Epithelial Cells. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 32(5). 303–316. 16 indexed citations
6.
Henig, Noreen, et al.. (2019). ISHLT Registry Data and Country Registries: Comparison of reported European Lung Transplant Activities in 2016. Transplantation. PA3367–PA3367. 1 indexed citations
7.
Sermet‐Gaudelus, Isabelle, John P. Clancy, David P. Nichols, et al.. (2018). Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis. Journal of Cystic Fibrosis. 18(4). 536–542. 43 indexed citations
8.
9.
Alton, Eric W.F.W., Alan Boyd, Jane C. Davies, et al.. (2016). Genetic medicines for CF: Hype versus reality. Pediatric Pulmonology. 51(S44). S5–S17. 36 indexed citations
10.
Raghu, Ganesh, Steven D. Nathan, Jürgen Behr, et al.. (2015). Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction. European Respiratory Journal. 46(5). 1370–1377. 105 indexed citations
11.
Anderson, Gregory G., Thomas Kenney, David L. MacLeod, Noreen Henig, & George A. O’Toole. (2013). Eradication of Pseudomonas aeruginosa biofilms on cultured airway cells by a fosfomycin/tobramycin antibiotic combination. PMC. 1 indexed citations
12.
Tullis, D. Elizabeth, Jane L. Burns, George Retsch‐Bogart, et al.. (2013). Inhaled aztreonam for chronic Burkholderia infection in cystic fibrosis: A placebo-controlled trial. Journal of Cystic Fibrosis. 13(3). 296–305. 39 indexed citations
13.
Grieve, Andrew P., J. Curram, Lutz Harnisch, et al.. (2013). Advancing Clinical Trial Design in Pulmonary Hypertension. Pulmonary Circulation. 3(1). 217–225. 14 indexed citations
14.
Bilton, Diana, Noreen Henig, Brian Morrissey, & Mark H. Gotfried. (2006). Addition of Inhaled Tobramycin to Ciprofloxacin for Acute Exacerbations of Pseudomonas aeruginosa Infection in Adult Bronchiectasis. CHEST Journal. 130(5). 1503–1510. 119 indexed citations
15.
Ziedalski, Tomasz M., Peter N. Kao, Noreen Henig, Susan S. Jacobs, & Stephen J. Ruoss. (2006). Prospective Analysis of Cystic Fibrosis Transmembrane Regulator Mutations in Adults With Bronchiectasis or Pulmonary Nontuberculous Mycobacterial Infection. CHEST Journal. 130(4). 995–1002. 90 indexed citations
16.
Ordoñez, Claudia L., Noreen Henig, Nicole Mayer-Hamblett, et al.. (2003). Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 168(12). 1471–1475. 144 indexed citations
17.
Vaszar, Laszlo T., Ann Weinacker, Noreen Henig, & Thomas A. Raffin. (2002). Ethical Issues in the Long-Term Management of Progressive Degenerative Neuromuscular Diseases. Seminars in Respiratory and Critical Care Medicine. 23(3). 307–314. 4 indexed citations
18.
Henig, Noreen. (2001). Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis. Thorax. 56(4). 306–311. 101 indexed citations
19.
Henig, Noreen, et al.. (2000). Effect of Recombinant Human Platelet-activating Factor-Acetylhydrolase on Allergen-induced Asthmatic Responses. American Journal of Respiratory and Critical Care Medicine. 162(2). 523–527. 51 indexed citations
20.
Henig, Noreen & Moira L. Aitken. (1997). Update on clinical trials of cystic fibrosis. Current Opinion in Pulmonary Medicine. 3(6). 404–409. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shaoyan Zhang Breakdown of academic impact, for papers by K. Randall Young Breakdown of academic impact, for papers by Amy O’Brien-Ladner Breakdown of academic impact, for papers by Dominique Grenet Breakdown of academic impact, for papers by Rita Padoan Breakdown of academic impact, for papers by David A. Waltz Breakdown of academic impact, for papers by Meng‐Chih Lin Breakdown of academic impact, for papers by Nobuhiko Nagata Breakdown of academic impact, for papers by J. Alastair Innes Breakdown of academic impact, for papers by Daniel Gelfond
Rankless by CCL
2026